title: Treatment of Myocardium avium complex infection: does the beige mouse model predict therapeutic outcome in humans?
abstract: To determine the predictive value of a standard murine model in the treatment of disseminated Myocardium avium complex (MAC) infection, beige mice were infected with MAC strains isolated from human immunodeficiency virus-infected patients and treated with the same antibiotic (ethambutol, clofazimine, or rifampin) that had been administered to the subject from whom that strain had been recovered. While ethambutol had the greatest bacteriologic efficacy in humans (mean decrease +/-SD, 1.0+/-0.5 log 10 cfu/mL of blood), clofazimine had the greatest bacteriostatic efficacy in mice (mean decrease +/- SD, 2.8 +/- 0.7 log(10) cfu/g of tissue). A linear correlation was not observed between bacteriostatic activity in mouse liver or spleen and the degree of bacteriologic response in humans (P > or = to .1). Odds ratios for a response in humans based on a bacteriologic response in mice were not significant for each agent (P > or = to .1, all cases).
authors.affiliation: Division of Infectious Diseases, Department of Medicine, Santa Clara Medical Center, San Jose, CA 95128, USA.
authors.forename: J P
authors.initials: JP
authors.lastname: Sison
authors.forename: Y
authors.initials: Y
authors.lastname: Yao
authors.forename: C A
authors.initials: CA
authors.lastname: Kemper
authors.forename: J R
authors.initials: JR
authors.lastname: Hamilton
authors.forename: E
authors.initials: E
authors.lastname: Brummer
authors.forename: D A
authors.initials: DA
authors.lastname: Stevens
authors.forename: S C
authors.initials: SC
authors.lastname: Deresinski
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy / Q000382:microbiology; D000818:Animals; D000995:Antitubercular Agents / Q000627:therapeutic use*; D002991:Clofazimine / Q000627:therapeutic use; D015169:Colony Count, Microbial; D004195:Disease Models, Animal; D004977:Ethambutol / Q000627:therapeutic use; D006801:Humans; D008099:Liver / Q000382:microbiology; D051379:Mice; D015270:Mycobacterium avium-intracellulare Infection / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D012293:Rifampin / Q000627:therapeutic use; D013045:Species Specificity; D013154:Spleen / Q000382:microbiology
chemical_list: D000995:Antitubercular Agents; D004977:Ethambutol; D002991:Clofazimine; D012293:Rifampin